期刊文献+

急性颅内大动脉梗死静脉溶栓禁忌患者多模式血管再通术分析 被引量:4

Multimodal vascular recanalization for acute intracranial large artery infarction in patients with contraindications of venous thrombolysis
下载PDF
导出
摘要 目的探讨Solitaire支架结合Gateway球囊导管多模式血管再通术治疗急性颅内大动脉梗死静脉溶栓禁忌患者的效果,并与桥接治疗作比较。方法回顾性分析2015年1月至2017年12月采用Solitaire AB支架取栓治疗的22例急性颅内大动脉梗死患者临床资料。其中男13例,女9例,年龄42~81岁;均有静脉溶栓禁忌证,13例超过溶栓时间窗(6例为醒后卒中)。CT或MR检查后予直接取栓或多模式血管再通治疗。比较患者术前和出院时美国国立卫生研究院卒中量表(NIHSS)评分,采用改良Rankin量表(mRS)评分评估预后。结果 22例患者中20例闭塞血管成功开通,再通率90.9%。术后开通血管患者改良脑梗死溶栓(mTICI)治疗后血流分级均≥Ⅱb级,穿刺至开通时间30~125 min(3例>120 min),平均(1.64±0.73) h。NIHSS评分由术前平均(17.06±9.18)分改善至出院时平均(6.35±4.37)分,疗效确定(P<0.01)。90 d随访显示14例mRS评分≤2,预后良好率为63.6%,死亡1例。结论严格掌握适应证情况下,多模式血管再通术治疗急性颅内大动脉梗死安全有效,与桥接治疗相比有更低的术后脑出血率(9.1%)和死亡率(4.5%)。Gateway球囊导管既可作为微导管用于接触性动脉溶栓,又可用于碎栓、血管扩张,可有效提高再通率。 Objective To investigate the curative efficacy of multimodal vascular recanalization by using Solitaire stent combined with Gateway balloon catheter in treating acute ischemic stroke(AIS) in patients with contraindications of intravenous thrombolysis, and to compare the efficacy with that of bridging treatment. Methods The clinical data of 22 patients with AIS, who received thrombectomy with Solitaire AB stents during the period from January 2015 to December 2017 in No.85 Hospital of People’s Liberation Army of China, were retrospectively analyzed. The patients included 13 males and 9 females, with the age of 42-81 years old. All the 22 patients had contraindications of intravenous thrombolysis. In 13 patients, the interval between the onset of AIS and the initial medical visit was beyond thrombolytic time window(6 patients had wake-up stroke). After CT or MRI examinations, direct thrombectomy or multimodal vascular recanalization was carried out. National Institutes of Health Stroke Scale(NIHSS) score was used to assess the scores, and modified Rankin Scale(mRS) was adopted to evaluate the prognosis. Results Of the 22 patients, successful vascular recanalization was achieved in 20, the recanalization rate was 90.9%. In all 20 patients who got vascular recanalization after treatment, the mTICI vascularization grade was ≥Ⅱb. The time from puncturing to vascular recanalization ranged from 30 to 125 minutes(>120 minutes in 3 patients), with a mean of(1.64±0.73) hours. NIHSS score was improved from preoperative(17.06±9.18) points to(6.35±4.37) points at the time of discharge from hospital, and the curative effect was reliable(P<0.01). Follow-up examinations 90 days after the treatment showed that mRS≤2 was seen in 14 patients, the good prognosis rate was 63.64%,and death o ccurred in one patient. Conclusion Under the condition when the indications are strictly observed, multimodal vascular recanalization is safe and effective for the treatment of acute intracranial large artery infarction. Compared with bridging treatment, multimodal vascular recanalization carries lower rate of postoperative intracerebral hemorrhage(9.1%) and lower rate of mortality(4.5%). Gateway balloon catheter can be used not only for microcatheter-directed arterial thrombolysis but also for thrombectomy and blood vessel dilatation, which can effectively improve the recanalization rate.
作者 卫杰 武玉军 刘洁怡 韦道明 WEI Jie;WU Yujun;LIU Jieyi;WEI Daoming(Department of Neurology,No.85 Hospital of People's Liberation Army,Shanghai 200052,China)
机构地区 解放军第
出处 《介入放射学杂志》 CSCD 北大核心 2019年第2期170-174,共5页 Journal of Interventional Radiology
关键词 Solitaire支架 急性颅内大动脉梗死 多模式血管再通 Solitaire stent acute intracranial large artery infarction multimodal vascular recanalization
  • 相关文献

参考文献7

二级参考文献150

  • 1丁宏岩,董强.基底动脉梗死的治疗:动脉和静脉溶栓效果比较的系统分析[J].中国卒中杂志,2006,1(6):414-416. 被引量:127
  • 2Wahlgren N, Ahrced N, Davalos A, et al; SITS-MOST Investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITSMOST): an observational study. Lancet, 2007, 369: 275-282.
  • 3Lyden PD, ed. Thrombolytic Therapy for Acute Stroke. 2nd ed. Totowa, NJ: Hmreana Press, 2005.
  • 4Wardlaw JM, Smdercock PA, Berg: E. Throrrbolytic therapy with recoinbinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cunaflative meta-analysis. Stroke, 2003, 34: 1437-1442.
  • 5Wardlaw JM, Zoppo G, Yamaguchi T, et al. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev, 2003, (4): CD000213.
  • 6Shanna M, Clark H, Armour T, et al. Acute stroke: evaluation and treatment. Evid Rep Technol Assess (Sunmm), 2005, (127): 1-7.
  • 7Hill MD, Buchan AM; Canadian Alteplase for Stroke Effectiveness Study (CASES) Investigators. Throrrbolysis for acute ischemic stroke: results of the Canadian Altephse for Stroke Effectiveness Study. CMAJ, 20(0, 172: 1307-1312.
  • 8Chung H, Refoios Canto R, Canto RR, et al. Alteplase for the treatment of acute ischaemic stroke: NICE technology appraisal guidance. Heart, 2007, 93: 1616-1617.
  • 9Saver JL, Smith EE, Fonarow GC, et al; GWTG-stroke Steering Committee and Investigators. The "golden hour" and acute brain ischemia: presenting features and lytic therapy in > 30,000 patients ariving within 60 minutes of stroke onset. Stroke, 2010, 41: 1431-1439.
  • 10Scott PA, Xu Z, Meurer WJ, et al. Attitudes and beliefs of Michigan emergmcy physicians toward tissue plasminogen activator use in stroke: baseline survey results from the INcreasing Stroke Treatment through INteractive behavioral Change Tactic (INSTINCT) trial hospitals. Stroke, 2010, 41: 2026-2032.

共引文献1460

同被引文献45

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部